» Articles » PMID: 19446720

CXCR4 and Mobilization of Hematopoietic Precursors

Overview
Journal Methods Enzymol
Specialty Biochemistry
Date 2009 May 19
PMID 19446720
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The binding of the chemokine [C-X-C motif] ligand 12 (CXCL12 or stromal cell-derived factor 1alpha [SDF-1alpha]) constitutively produced by bone marrow stromal cells and osteoblasts, to the CXC receptor (CXCR) 4, a transmembrane chemokine receptor expressed on hematopoietic stem and progenitor cells (HSPCs), has emerged as a key signal for HSPC trafficking to and from the bone marrow. Disruption of CXCL12/CXCR4 signaling causes leukocytosis, with the release of HSPCs, neutrophils, and lymphocytes into the peripheral blood. Although mobilized peripheral blood has become the preferred source of stem cells for both autologous and allogeneic transplantation, the optimum strategy for obtaining mobilized products from donors is the subject of ongoing study. Granulocyte colony-stimulating factor (G-CSF) and plerixafor (AMD3100) are two agents used clinically to induce HSPC mobilization by disruption of the CXCL12/CXCR4 interaction. This chapter describes current procedures used to phenotypically and functionally characterize murine and human HSPCs mobilized by G-CSF or plerixafor.

Citing Articles

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor.

Crees Z, Rettig M, Bashey A, Devine S, Jaglowski S, Wan F Blood Adv. 2023; 7(18):5210-5214.

PMID: 37327120 PMC: 10500469. DOI: 10.1182/bloodadvances.2023010407.


Dual CXCR4 and E-Selectin Inhibitor, GMI-1359, Shows Anti-Bone Metastatic Effects and Synergizes with Docetaxel in Prostate Cancer Cell Intraosseous Growth.

Festuccia C, Mancini A, Gravina G, Colapietro A, Vetuschi A, Pompili S Cells. 2019; 9(1).

PMID: 31877673 PMC: 7017374. DOI: 10.3390/cells9010032.


The pleiotropic cardiovascular effects of dipeptidyl peptidase-4 inhibitors.

Avogaro A, Fadini G Br J Clin Pharmacol. 2018; 84(8):1686-1695.

PMID: 29667232 PMC: 6046494. DOI: 10.1111/bcp.13611.


Gold Nanoclusters Doped with (64)Cu for CXCR4 Positron Emission Tomography Imaging of Breast Cancer and Metastasis.

Zhao Y, Detering L, Sultan D, Cooper M, You M, Cho S ACS Nano. 2016; 10(6):5959-70.

PMID: 27159079 PMC: 5479491. DOI: 10.1021/acsnano.6b01326.


Ulocuplumab (BMS-936564 / MDX1338): a fully human anti-CXCR4 antibody induces cell death in chronic lymphocytic leukemia mediated through a reactive oxygen species-dependent pathway.

Kashyap M, Kumar D, Jones H, Amaya-Chanaga C, Choi M, Melo-Cardenas J Oncotarget. 2015; 7(3):2809-22.

PMID: 26646452 PMC: 4823073. DOI: 10.18632/oncotarget.6465.